Arab Health 2022
Arab Health & Austrade Healthcare Program
Dubai, UAE – 24th to 27th Jan, 2022
Join us at Arab Health 2022 where Genetic Signatures will be exhibiting in collaboration with Austrade and Investment NSW. Genetic Signatures was selected by Austrade to participate in a business matchmaking program for the Middle East region. The involvement presents opportunities for Genetic Signatures to expand our presence in the Middle East and raise the profile of our unique molecular diagnostic solutions for respiratory and enteric disease, sexual health, drug-resistance, and other key disease areas. Arab Health will be hosted at the Dubai World Trade Centre with a live in-person event from Jan 24th-27th and online attendance between Jan 5th-Feb 28th. The international event will involve around 190+ participating nations.
Visit the Arab Health website to learn more about the event or to submit your registration – https://www.arabhealthonline.com/en/Home.html
Genetic Signatures is a specialist molecular diagnostics (MDx) company focused on the development of real-time PCR based products for the routine detection of infectious diseases.
Our proprietary 3baseTM technology provides hospital and pathology laboratories with the ability to screen for a wide array of infectious pathogens with a high degree of specificity and reliability, in a rapid throughput (time to result) environment.